Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

New England Journal of Medicine - Tập 355 Số 26 - Trang 2733-2743 - 2006
Charles E. Geyer1, John Forster2, Deborah Lindquist3, Stephen Chan4, C Romieu5, Tadeusz Pieńkowski6, Agnieszka Jagiełło-Gruszfeld7, John Crown8, Arlene Chan9, Bella Kaufman10, Dimosthenis Skarlos11, Mario Campone12, N. Davidson13, Mark S. Berger14, Cristina Oliva15, Stephen D. Rubin14, Steven Stein14, David Cameron16
1Allegheny General Hospital, Pittsburgh
2GlaxoSmithKline, Greenford, United Kingdom
3US Oncology, Sedona, AZ
4Nottingham University Hospitals, Nottingham, United Kingdom,
5Centre Régional de Lutte contre le Cancer Val d'Aurelle Montpellier, France
6Centrum Onkologii Klinika Nowotworów Piersi i Chirurgii, Warsaw, Poland
7Zaklad Opieki Zdrowotnej MSWiA, Olsztyn, Poland
8Ireland Cooperative Oncology Research Group, Dublin
9Mount Medical Centre, Perth, Australia
10Chaim Sheba Medical Center, Tel-Hashomer, Israel
11Errikos Dynan Hospital, Athens
12Centre René Gauducheau, Saint Herblain, France
13Broomfield Hospital, Chelmsford, United Kingdom
14GlaxoSmithKline, Collegeville, PA
15GlaxoSmithKline, Middlesex, United Kingdom
16Western General Hospital, Edinburgh

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/canjclin.55.2.74

10.1126/science.3798106

10.1056/NEJM200103153441101

10.1200/JCO.20.3.719

Cobleigh MA, 1999, J Clin Oncol, 17, 2639, 10.1200/JCO.1999.17.9.2639

10.1056/NEJMoa052122

10.1056/NEJMoa052306

10.1200/JCO.2004.06.557

10.1634/theoncologist.11-4-318

Rusnak DW, 2001, Mol Cancer Ther, 1, 85

10.1158/0008-5472.CAN-04-1168

10.1158/0008-5472.CAN-05-1182

Schwartz G, 2004, Proc Am Soc Clin Oncol, 23, 212s

10.1093/jnci/92.3.205

10.1016/0378-3758(94)90187-2

Clayton AJ, 2004, Br J Cancer, 91, 639, 10.1038/sj.bjc.6601970

10.1200/JCO.2004.01.175

10.1200/JCO.2005.12.157